Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Roy Blunt sold 600 shares of the stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total transaction of $157,608.00. Following the transaction, the director directly owned 4,589 shares of the company’s stock, valued at $1,205,438.52. The trade was a 11.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Tenet Healthcare Stock Up 0.2%
Shares of NYSE THC opened at $262.75 on Monday. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The business’s 50 day moving average is $200.19 and its two-hundred day moving average is $201.43. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $265.32. The firm has a market cap of $21.16 billion, a price-to-earnings ratio of 10.13, a PEG ratio of 1.00 and a beta of 1.23.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same period last year, the business posted $4.02 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Research analysts predict that Tenet Healthcare Corporation will post 21.09 EPS for the current year.
Institutional Investors Weigh In On Tenet Healthcare
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on THC. Guggenheim increased their price target on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th. Piper Sandler set a $308.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Raymond James Financial set a $270.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Stephens reaffirmed an “overweight” rating and set a $285.00 price objective on shares of Tenet Healthcare in a research report on Monday, July 27th. Finally, Barclays lifted their target price on Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a report on Friday, July 24th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average price target of $271.00.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
- Five stocks we like better than Tenet Healthcare
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
- Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
